The emerging role of lncRNAs in the regulation of cancer stem cells
R Castro-Oropeza, J Melendez-Zajgla, V Maldonado… - Cellular Oncology, 2018 - Springer
Background Tumors contain a functional subpopulation of cells that exhibit stem cell
properties. These cells, named cancer stem cells (CSCs), play significant roles in the …
properties. These cells, named cancer stem cells (CSCs), play significant roles in the …
Targeting microRNAs in cancer gene therapy
W Ji, B Sun, C Su - Genes, 2017 - mdpi.com
MicroRNAs (miRNAs) are a kind of conserved small non-coding RNAs that participate in
regulating gene expression by targeting multiple molecules. Early studies have shown that …
regulating gene expression by targeting multiple molecules. Early studies have shown that …
[HTML][HTML] MiR-145: a potential biomarker of cancer migration and invasion
WX Xu, Z Liu, F Deng, DD Wang, XW Li… - American journal of …, 2019 - ncbi.nlm.nih.gov
MircoRNAs (miRNAs) are a diverse family of highly-conserved small non-coding RNAs,
which range from approximately 18 to 25 nucleotides in size. They regulate gene expression …
which range from approximately 18 to 25 nucleotides in size. They regulate gene expression …
The crucial role of ZEB2: from development to epithelial‐to‐mesenchymal transition and cancer complexity
Zinc finger E‐box binding homeobox 2 (ZEB2) is a DNA‐binding transcription factor, which
is mainly involved in epithelial‐to‐mesenchymal transition (EMT). EMT is a conserved …
is mainly involved in epithelial‐to‐mesenchymal transition (EMT). EMT is a conserved …
Cervical cancer markers: epigenetics and microRNAs
V Laengsri, U Kerdpin, C Plabplueng… - Laboratory …, 2018 - academic.oup.com
Gynecologic malignant neoplasms are a severe health problem among female patients, of
which cervical cancer (CC), in particular, is a common disease leading to high mortality …
which cervical cancer (CC), in particular, is a common disease leading to high mortality …
The role of miRNAs in the invasion and metastasis of cervical cancer
J Wang, L Chen - Bioscience reports, 2019 - portlandpress.com
Cervical cancer (CC) with early metastasis of the primary tumor results in poor prognosis
and poor therapeutic outcomes. MicroRNAs (miRNAs) are small, noncoding RNA molecules …
and poor therapeutic outcomes. MicroRNAs (miRNAs) are small, noncoding RNA molecules …
Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA
T Mitra, S Elangovan - Molecular and Cellular Biochemistry, 2021 - Springer
Cervical cancer (CC) is one of the leading causes of death in women due to cancer and a
major concern in the developing world. Persistent human papilloma virus (HPV) infection is …
major concern in the developing world. Persistent human papilloma virus (HPV) infection is …
MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis
C Lu, Z Shan, J Hong, L Yang - … journal of oncology, 2017 - spandidos-publications.com
MicroRNAs (miRNAs) have important roles in various cancers, including non-small cell lung
cancer (NSCLC). Although several miRNAs have reported to be involved in the …
cancer (NSCLC). Although several miRNAs have reported to be involved in the …
Targeting epithelial–mesenchymal plasticity in cancer: clinical and preclinical advances in therapy and monitoring
The concept of epithelial–mesenchymal plasticity (EMP), which describes the dynamic flux
within the spectrum of phenotypic states that invasive carcinoma cells may reside, is being …
within the spectrum of phenotypic states that invasive carcinoma cells may reside, is being …
miR‐145 inhibits aerobic glycolysis and cell proliferation of cervical cancer by acting on MYC
C Hu, T Liu, W Zhang, Y Sun, D Jiang… - The FASEB …, 2023 - Wiley Online Library
Nearly half a million women are diagnosed with cervical cancer (CC) each year, with the
incidence of CC stabilizing or rising in low‐income and middle‐income countries. Cancer …
incidence of CC stabilizing or rising in low‐income and middle‐income countries. Cancer …